Data & Analytics

Discovering Meaningful Insights in Patient Journeys: Identifying Hidden Patterns Using Advanced Analytics

Discovering Meaningful Insights in Patient Journeys: Identifying Hidden Patterns Using Advanced Analytics

During this seminar, attendees will learn how advanced data analytics can be applied to gain a measurable competitive advantage.

Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

In this webcast, TrialCard VP of analytic services Paul LeVine and senior analytic consultant Robert Leedom underscore how affordability programs provide the ideal venue for focusing on adherence issues.

Podcast: Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

Podcast: Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

In this sponsored podcast, MM&M's Larry Dobrow speaks with Robert Leedom, senior analytics consultant at TrialCard, and Paul LeVine, VP of analytic services for TrialCard, about how to reach patients by leveraging brand data.

Government watchdog finds that most but not all generic drug prices are falling

Government watchdog finds that most but not all generic drug prices are falling

By

A new government investigation found that most but not all prices for generic drugs dispensed by Medicare Part D fell from 2010 to 2015.

Report: 3 tips for pharma to provide beyond-the-pill services

Report: 3 tips for pharma to provide beyond-the-pill services

By

Physicians are seeking beyond-the-pill services from drugmakers, but few sales reps shares details with docs about these programs, a new report finds.

3 Lessons on Behavior Change from Pokémon Go

3 Lessons on Behavior Change from Pokémon Go

Jawbone data shows that people mentioning Pokémon Go in their comments have been walking 62.5% more than usual.

Expect healthcare agencies to make more digital acquisitions: report

Expect healthcare agencies to make more digital acquisitions: report

By

Mergers and acquisitions targeting digital and data capabilities increased 60% to $1 billion in the first half of 2016.

Five things for pharma marketers to know: Wednesday, July 27, 2016

Five things for pharma marketers to know: Wednesday, July 27, 2016

By

IBM to help analyze data about the spread of Zika; Grassley to investigate Part D program; Lilly CEO to retire

Five things for pharma marketers to know: Wednesday, July 20, 2016

Five things for pharma marketers to know: Wednesday, July 20, 2016

By By

Spending on CME rose in 2015; the FDA approves Valeant's Relistor; the Justice Department aims to block insurer merger

The Future of Data-Driven Marketing is Now

The Future of Data-Driven Marketing is Now

Healthcare marketing is evolving more rapidly than ever before — and not surprisingly, the demand for smarter media campaign measurement is increasing as a result.

No free lunch for docs: Sponsored meals linked to more prescriptions

No free lunch for docs: Sponsored meals linked to more prescriptions

By

A new analysis suggests that $20 industry-sponsored meals may sway docs' prescribing habits.

Panel: Why data is the first step in telling a human story

Panel: Why data is the first step in telling a human story

By

The ability to pair data with a story or a human emotion is often easier for women.

The CIO, reimagined for pharma

The CIO, reimagined for pharma

By

Despite the increasing importance of the CIO post, top technology professionals still find it hard to break into the uppermost ranks at life-sciences companies.

Pharma is reluctant to adopt digital in R&D: survey

Pharma is reluctant to adopt digital in R&D: survey

By

Only 55% of the surveyed pharmaceutical executives said they are adopting digital as a key strategy in R&D.

Five things for pharma marketers to know: Thursday, May 26, 2016

Five things for pharma marketers to know: Thursday, May 26, 2016

By

BIO report finds success rate in Phase-I is 10%; Dunsire departs Forum after failed trials; the FDA issues two warning letters

Conflicting polls highlight uncertainty about the public's opinion of pharma

Conflicting polls highlight uncertainty about the public's opinion of pharma

By

Two recent polls paint a complicated picture of the public's opinion of the pharma industry.

Five things for pharma marketers to know: Friday, May 20, 2016

Five things for pharma marketers to know: Friday, May 20, 2016

By

Keytruda's survival benefit is reinforced by new study; drugmakers reference patient-assistance programs in debate over drug prices; China cuts drug prices

Ponemon: Cybercrime is top cause for healthcare data breaches

Ponemon: Cybercrime is top cause for healthcare data breaches

A 69% majority of healthcare organizations said they believe their industry is more vulnerable to data breaches than other business sectors.

2016 Pharma Report: All the data in one place

2016 Pharma Report: All the data in one place

Learn more about the top therapeutic categories by sales, top companies by revenue, top drugs by sales, and more.

Do We Need Formal Surveys Anymore?

Do We Need Formal Surveys Anymore?

"Social can enable a better starting point to yield better questions and thus make surveys less in number yet greater in value."

Challenges exist, even as excitement grows for big data market

Challenges exist, even as excitement grows for big data market

By

The move away from a fee-for-service reimbursement model and the arrival of promising new technology have created demand for big data in healthcare.

U.S. drug spend jumped 12% in 2015

U.S. drug spend jumped 12% in 2015

By

2015 marks the second straight double digit increase in spend, which was driven by recent launches and specialty brands.

Five things for pharma marketers to know: Friday, April 8, 2016

Five things for pharma marketers to know: Friday, April 8, 2016

By

Analyst survey says docs want outcomes benefit from PCSK9s; Allergan licenses early-stage Alzheimer's drugs; Pfizer and IBM partner in Parkinson's disease

Eli Lilly's failed trial could spell the end for CETP inhibitors

Eli Lilly's failed trial could spell the end for CETP inhibitors

By

The results of a failed trial for Lilly's CEPT inhibitor has analysts saying there is little hope for Merck's drug in the same class.

Healthcare industry seeks to reform its position as hacking target

Healthcare industry seeks to reform its position as hacking target

Given the value of its data and its relatively backward security measures, the healthcare industry has become a prime target for hackers. But industry experts say changes are afoot.

Finding the Right Time to Talk to Doctors

Finding the Right Time to Talk to Doctors

Time is everything, yet no one has enough of it. But especially in healthcare marketing, time and timing win customers.

Easy navigation beats out trustworthiness for health info, survey finds

Easy navigation beats out trustworthiness for health info, survey finds

By

Consumers are more likely to use health information websites they find easier to navigate than those perceived as trustworthy, like government sites, new research shows.

Five things for pharma marketers to know: Tuesday, March 1, 2016

Five things for pharma marketers to know: Tuesday, March 1, 2016

By

Analysis questions Addyi's effectiveness; Horizon is subpoenaed about its patient assistance programs; AstraZeneca sells non-U.S. rights to constipation drug

How Obama's Precision Medicine Initiative will Change Healthcare Marketing

How Obama's Precision Medicine Initiative will Change Healthcare Marketing

With these changes coming to healthcare from precision medicine, it may no longer be acceptable to do generic or broad marketing campaigns in hopes of catching the small group of people who may benefit from a device or treatment.

Havas Health partners with data firm to find rare disease patients

Havas Health partners with data firm to find rare disease patients

By

The agency announced a partnership with Vencore Health Analytics to help pair rare disease patients with drugmakers.

OPINION

Email Newsletters